Novartis R&D Day

Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.

Dec 05, 2019

Our drug discovery and development engine has the scope and scale to innovate the next generation of medicines. We’re harnessing powerful and advanced therapy platforms to take on big scientific challenges and find opportunities to develop breakthrough medicines for patients.

Learn more in our media release.

R&D and Investor Update

Watch the webcast (05.12.19 14:00 CET - 13:00 GMT - 08:00 EST)

Download the presentation (PDF 8.1 MB)

Novartis R&D on Social Media

    View this post on Instagram         

You need a passionate and innovative team to build out one of the most innovative pipelines in the industry, and some of them are pictured here. As Novartis wraps up a breakthrough year during which we had six new medicines approved—a rare scientific feat—we're gathering in London today to share a deeper look at our R&D efforts. I'm grateful we could share this moment together and look forward to our continued work to reimagine medicine for the world. #novartis #reimaginingmedicine

A post shared by Vas Narasimhan (@vasnarasimhan) on Dec 5, 2019 at 5:55am PST

Oncology research uncovers new insights about tumors.
Discovery

Can data from a heart disease trial lead to a potential cancer treatment?

 

Contact Media Relations

For media and journalist inquiries, please contact the Novartis Corporate Media Relations office by email.